CEA is a cell-surface glycoprotein that is normally expressed during embryogenesis, with little to no expression in normal tissue, and is used as a serum tumor marker in patients with pancreatic cancer [8]. This evidence concerns the gene CEACAM5 and familial pancreatic carcinoma.